专题：Neuroblastoma Research and Treatments

This cluster of papers represents a comprehensive exploration of neuroblastoma, covering topics such as genetic mutations (including ALK and MYCN), risk classification, staging systems, immunotherapy, and genomic analysis. The research also delves into therapy strategies and prognosis for patients with neuroblastoma.
最新文献
A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers

article Full Text OpenAlex

Exploring the Role of CDO1 in Breast Cancer: Insights into Tumor Biology and Therapeutic Potential

article Full Text OpenAlex

Case Report: Solitary adrenal metastasis from esophageal adenocarcinoma

article Full Text OpenAlex

Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas

review Full Text OpenAlex

Affinity Affects the Functional Potency of Anti-GD2 Antibodies by Target-Mediated Drug Disposition

article Full Text OpenAlex

ALK/ATR combination therapy is effective in neuroblastoma mouse tumors driven by MYCN

preprint Full Text OpenAlex

Composite gangliocytoma/neuroma and neuroendocrine tumor: a clinicopathologic, immunohistochemical, and molecular genetic study of 11 cases

article Full Text OpenAlex

Non-canonical activating roles of RCoR2 sustain transcription in adrenergic neuroblastoma

article Full Text OpenAlex

Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma

article Full Text OpenAlex

Phase I clinical trial of the bifunctional EGFR/TGF-β fusion protein ficerafusp alfa (BCA101) alone and in combination with pembrolizumab for advanced solid tumors

article Full Text OpenAlex

近5年高被引文献
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

review Full Text OpenAlex 8458 FWCI292.506

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019

article Full Text OpenAlex 1092 FWCI236.94

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016—2020

article Full Text OpenAlex 751 FWCI240.542

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

review Full Text OpenAlex 643 FWCI33.25

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 453 FWCI48.02

Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group

article Full Text OpenAlex 355 FWCI34.843

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma

article Full Text OpenAlex 347 FWCI80.671

Incidentally DiscoveredAdrenal Mass

book-chapter Full Text OpenAlex 304 FWCI16.948

Endocrine toxicities of immune checkpoint inhibitors

review Full Text OpenAlex 298 FWCI8.927

Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas

review Full Text OpenAlex 285 FWCI22.503